Clinical Trial Update: Placebo-controlled Study to Evaluate the Safety and Efficacy of GLK-221 Ophthalmic Solution in Subjects With Keratoconus [Phase 2]

View source ↗

Summary

A Phase 2 placebo-controlled study to evaluate the safety and efficacy of GLK-221 ophthalmic solution in subjects with keratoconus is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Keratoconus

Drugs mentioned

• GLK-221 Ophthalmic Solution

Snippet

Sponsor: Glaukos Corporation | Conditions: Keratoconus | Phase 2 | Status: RECRUITING